In addition, network analysis further demonstrates silencing of the ErbB2 pathway involved in epithelial-to-mesenchymal transition (EMT) and glycolysis dependent breast cancer cell migration [46] (Supplementary Figure 2). This evidence concerns the gene ERBB2 and breast carcinoma.